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One hundred and twenty-four cystic ﬁbrosis patients (lung transplant recipients
excluded) delivered 998 respiratory tract samples during a 12 month period,
and Haemophilus inﬂuenzae was isolated from 245 samples from 79 patients.
H. inﬂuenzae was cultured at least once from 27 of 27 (100%) patients below 6 years
of age, from 34 of 57 (60%) patients aged 6−17 years, and from 10 of 40 (25%)
adult patients (18 y). From 25 patients, H. inﬂuenzae was recovered from  half
of their samples, and these patients accounted for 55% of all isolates. Cultivation
of H. inﬂuenzae elicited treatment with oral amoxicillin (or amoxicillin-clavulanic
acid; in rare instances ciproﬂoxacin), also in the absence of symptoms. Severe
exacerbations were treated with intravenous cefuroxime or cetftriaxone. Fifteen
percent of the isolates produced b-lactamase, another 12% exhibited decreased sus-
ceptibility to ampicillin (low-BLNAR (beta-lactamase negative ampicillin-resistant)
H. inﬂuenzae), as evaluated by reduced susceptibility to oral cephalosporins by a
disc-diffusion assay. These rates were similar to the susceptibility levels observed
with H. inﬂuenzae cultured from non-CF patients. Whether the repeated isolation
of H. inﬂuenzae from the same patient is attributable to a chronic colonization with
a single strain is investigated by pulsed-ﬁeld gel electrophoresis.
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Introduction and Aims: We have shown the presence of aerobic and anaerobic
bacteria in adult CF patients when stable and during acute exacerbations. The aim
of this study was to determine if anaerobic bacteria are present in the lower airways
of paediatric CF patients and to determine their antimicrobial susceptibility.
Methods: Broncholaveolar lavage ﬂuid (BALF) samples were collected from 33 CF
children (mean age 9.4±0.9 yrs; range 1−19) at the University of North Carolina.
For culture detection, samples were plated on selective agars and bacteria quantiﬁed
by viable count and identiﬁed by PCR and sequencing of 16S rRNA genes.
Antimicrobial susceptibility was determined using E-tests. For molecular detection,
total DNA was extracted from BALF and bacterial species were identiﬁed by
terminal restriction fragment length polymorphism (T-RFLP) analysis.
Results: No bacteria were detected in 5/33 (15%) and 7/32 (22%) samples by
culture and T-RFLP, respectively. The most frequently isolated aerobic bacteria
was S. aureus (meticillin-sensitive and resistant) which was detected by culture in
13/33 (39%) samples. Anaerobically growing bacteria were cultured in 13/33 (39%)
samples with Prevotella (4 samples) and Propionibacterium (3 samples) species
predominating. T-RFLP detected anaerobic bacteria in 13/32 (41%) samples. The
anaerobes cultured were all susceptible to meropenem and piperacillin/tazobactam
but some resistance was apparent to metronidazole, clindamycin and tobramycin.
Conclusion: Anaerobic infection may occur early in CF pathogenesis. Culture and
molecular methods complement each other for detection of anaerobic organisms.
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CF patients produce large amounts of hypoxic/anaerobic plugs which may favour
the growth of strict anaerobes. Here we show that 25−69% of investigated CF
patients were infected with one or more anaerobs including Prevotella and Veionella
subspecies. In 75% of the patients, Prevotella species were present in numbers
of 105–107 CFU/ml sputum. Supernatant ﬂuids of Prevotella intermedia produced
cytotoxins for human respiratory epithelial cells and neutrophils. To assess whether
P. intermedia contributes to the pathophysiology of CF lung disease, membrane
proteins of P. intermedia strain 25611 were used in ELISA and Western blotting
to detect speciﬁc serum antibodies. CF patients had increased serum antibody
titers against P. intermedia compared to controls. Western blotting showed that
antibodies bound to membrane proteins of P. intermedia, identiﬁed by MALDI-TOF
as PIN AO373 and PIN AO107. These data suggest that cellular components of P.
intermedia can contribute to the CF pathophysiology by immune complex formation
thereby increasing inﬂammation. We also demonstrate that under anaerobic nutrient
limitation, P. intermedia successfully competes with P. aeruginosa for growth in
vitro and in a murine lung infection model. Taken together our data support previous
investigations that CF sputum specimens contain anaerobic organisms. The data
also suggest that strict anaerobic bacteria contribute to the pathophysiology of lung
disease in CF patients.
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Achromobacter xylosoxidans has been suggested as pathogen in lung disease of
cystic ﬁbrosis patients, but with no well established clinical relevance. We compared
the manual versus automated microbiological identiﬁcation and the susceptibility to
antimicrobial agents for A. xylosoxidans strains isolated from pediatric CF patients
seen at reference center at our State University Hospital. The microorganisms were
identiﬁed by 33 conventional tests (ASM – 2007), Vitek II BioMerieux® and the
LMG reference strains of A. xylosoxidans, A. denitriﬁcans and A. piechaudi as
control. The antimicrobial sensitivity was done by E-test®. For Achromobacter
discrimination PCR assay for 16S rRNA was used. From the 33 tests applied, only
reduction of nitrite to gas, OF glicose, OF xylose and growth at 42ºC were useful
for species discrimination. Vitek II® could identify LMG 1231 A. denitriﬁcans
correctly, A. piechaudii LMG 1873 only at genera level and A. xylosoxidans LMG
1863 was misidentiﬁed as B. bronchiseptica. Comparing with manual identiﬁca-
tion, Vitek II® identiﬁed correctly only 5/14 (36%) strains as A. xylosoxidans
and disagree with 9/14 (64%) identiﬁed as A. denitriﬁcans. The Etest® MIC
50% and 90% and range results were respectively in mg/mL: Ceftazidime: 6/12
(2−>256), Ciproﬂoxacin: 2/>32 (0.75−>32), Meropenem:0.19/>32 (0.094−>32),
Minocyclin: 2/3(1.5−6), Sulfatrim: 0.19/>32 (0.023−>32), Tygeciclin:1.5/3(0.38−6)
and Polymyxin B:3/4(1.5−6). These results conﬁrms the difﬁculty to identify this
microorganism and the limited options of therapy drugs.
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